Monitoring of asthma outpatients after adapting treatment to meet international guidelines;La población de asmáticos ambulatorios y su control tras adaptar el tratamiento a las recomendaciones internacionales (ASMACAP I)

Archivos de Bronconeumologia

Volumn 43, Issue 1, 2007, Pages 29-35

  Morell, Ferran ^a   Genover, Teresa ^a   Reyes, Leonardo ^b   Benaque, Esther ^b   Roger, Àlex ^a   Ferrer, Jaume ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^b Centre d'Assistència Primària Rio de Janeiro   (Spain)

Author keywords

Adherence; Asthma; Education

Indexed keywords

ANTIHISTAMINIC AGENT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; THEOPHYLLINE;

ADULT; AGED; ARTICLE; ASTHMA; CONTROLLED STUDY; DISEASE CONTROL; DISEASE EXACERBATION; DISEASE SEVERITY; FEMALE; HEALTH CARE; HEALTH SERVICE; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTPATIENT; PATIENT MONITORING; PRACTICE GUIDELINE; QUESTIONNAIRE; TREATMENT PLANNING;

EID: 33846901162     PISSN: 03002896     EISSN: None     Source Type: Journal    
DOI: 10.1157/13096998     Document Type: Article

References (28)

1. Grupo Español del Estudio del Asma. Estudio Europeo del Asma. Prevalencia de síntomas relacionados con el asma en cinco áreas españolas. Med Clin (Barc). 1995;104:487-92.
2. European Community Respiratory Health Survey. Variations in the prevalence of respiratory symptoms, self-reported asthma, and use of asthma medication in the European Community Respiratory Health Survey (ECRHS). Eur Respir J. 1996;9:687-95.
3. Rabe KF, Vermeire PA, Soriano JB, Maier WC. Clinical management of asthma in 1999; the Asthma Insights and Reality in Europe (AIRE) study. Eur Respir J. 2000;16:802-7.
4. Adams RS, Fuhlbrigge A, Guilbert T, Lozano P, Martínez F. Inadequate use of asthma medication in the United States: results of the asthma in America national population survey. J Allergy Clin Immunol. 2002;10:58-64.
5. Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention. NHLBI/WHO Workshop Report. NIH publication 1995; 02-3659. Update of Executive Committee in 2002. Disponible en: www.ginasthma.com. p. 115.
6. Gibson PC. Monitoring the patient with asthma: an evidence-based approach. J Allergy Clin Immunol. 2000;106:17-26.
7. Serra-Batlles J, Plaza V, Morejón E, Comella A, Brugues J. Costs of asthma according to the degree of severity. Eur Respir J. 1998;12:1322-6.
8. Antonicelli L, Bucca C, Neri M, De Benedetto F, Sabbatani P, Bonifazi F, et al. Asthma severity and medical resource utilisation. Eur Respir J. 2004;23:723-9.
9. Ignacio-García JM, González-Santos P. Asthma sef-management education program by home monitoring of peak expiratory flow. Am J Respir Crit Care Med. 1995;151:353-9.
10. López Viña A. Actividades para fomentar el cumplimiento terapéutico en el asma. Arch Bronconeumol. 2005;41:334-40.
11. Bender B, Milgrom H, Apter A. Adherence intervention research; what have we learned and what do we do next? J Allergy Clin Immunol. 2003;112:489-94.
12. Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention. NHLBI/WHO Workshop Report. Disponible en: www.ginasthma.com. p. 75.
13. Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention. NHLBI/WHO Workshop Report. NIH publication 1995; 02-3659. Update of Executive Committee in 2002. Disponible en: www.ginasthma.com. p. 68.
14. Gibson PG, Coughlan J, Wilson AJ, Hensley MJ, Abramson M, Walters EH. Limited (information only) asthma education on health outcomes of adults with asthma. En: Cochrane Library, Issue 1, 2001.
15. Gibson PG, Coughlan J, Wilson AJ, Abramson M, Bauman A, Hensley MJ, et al. Self-management education and regular practitioner review for adults with asthma. En: Cochrane Library, Issue 2, 2002.
16. Plaza Moral V. Médico de familia y neumólogo: ¿coordinación o confrontación? Propuesta de un esquema de relación entre atención primaria y neumología. Arch Bronconeumol. 2004;40:15-7.
17. SEPAR y semFYC. Recomendaciones para la atención del paciente con asma. Arch Bronconeumol. 1998;34:394-9.
18. Borderías Clau L, Zabaleta Murguionda M, Riesco Miranda JA, Pellicer Ciscard C, Hernández Hernández JR, Carrillo Díaz T, et al. Coste y manejo de una crisis asmática en el ámbito hospitalario de nuestro medio (estudio COAX en servicios hospitalarios). Arch Bronconeumol. 2005;41:313-21.
19. Basagana X, Sunyer J, Zock JP, Kogevinas M, Urrutia I, Maldonado JA, et al. Incidence of asthma and its determinants among adults in Spain. Am J Respir Crit Care Med. 2001;164:1133-7.
20. Zock JP, Kogevinas M, Sunyer J, Jarvis D, Toren K, Anto JM. Asthma characteristics in cleaning workers, workers in other risk jobs and office workers. Eur Respir J. 2002;20:679-85.
21. Soriano JB, Tobias A, Kogevinas M, Sunyer J, Sáez M, Martínez-Moratalla J, et al. Atopy and nonspecific bronchial responsiveness. A population-based assessment. Spanish Group of the European Community Respiratory Health Survey. Am J Respir Crit Care Med. 1996;154:1636-40.
22. Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention. NHLBI/WHO Workshop Report. NIH publication 1995; 02-3659. Update of Executive Committee in 2002. Disponible en: www.ginasthma.com. p. 40.
23. WHO Pharmaceutical Newsletter. 2003;2:4. Disponible en: http://www.fola.gov/bbs/topics/ANSWERS/2003/ANSO 1192.html
24. Anónimo. Rise d'episodis greus d'asma per salmeterol. Butlletí Groc. 2003;6:9-11.
25. Anderson HR, Ayres JG, Sturdy PM, Bland JM, Butland BK, Peckitt C, et al. Bronchodilator treatment and deaths from asthma: case-control study. BMJ. 2005;330:117.
26. Boushey HA, Sorkness CA, King TS, Sullivan SD, Fahy JV, Lazarus SC, et al. Daily versus as-needed corticosteroids for mild persistent asthma. N Engl J Med. 2005;352:1519-28.
27. Fabri L. Does mild persistent asthma require regular treatment? N Engl J Med. 2005;352:1589-90.
28. Muir Gray JA. Atención sanitaria basada en la evidencia. Madrid: Churchill-Livingstone; 1997. p. 67.